Benitec Biopharma BNTC
NASDAQ BNTC
$8.50 -0.54 (-5.97%)
At close: Oct 21, 2026 · 4:00 PM EDT

Benitec Biopharma (BNTC) Receivables - Other (2019 - 2020)

Updated

Benitec Biopharma's Receivables - Other came in at $21,000 for fiscal Q2 2021 (quarter ended Dec 31, 2020).

Analysis

Benitec Biopharma (BNTC) Receivables - Other (2019 - 2020) Analysis & Trends

At the end of FY2020 (ended Jun 30, 2020), Benitec Biopharma's Receivables - Other was $59,000, down 96.9% from FY2019.

  • Going back by fiscal year, Receivables - Other was $1.9 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Benitec Biopharma 392.02 Mn -169.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 21,000.00
Jun 30, 2020 59,000.00
Jun 30, 2019 1.90 Mn
API Access

Benitec Biopharma Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=BNTC&period=max&api_key=YOUR_API_KEY